Page last updated: 2024-09-04

moxifloxacin and 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one

moxifloxacin has been researched along with 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one)	Trials (6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one)	Recent Studies (post-2010) (6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one)
3,157	552	1,690	27	1	22

Protein Interaction Comparison

Protein	Taxonomy	6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one (IC50)
Chain A, Tyrosine-protein kinase SYK	Homo sapiens (human)	0.041
Chain A, Tyrosine-protein kinase SYK	Homo sapiens (human)	0.041
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Chain A, Tyrosine-protein kinase BTK	Homo sapiens (human)	0.29
Tyrosine-protein kinase JAK2	Homo sapiens (human)	0.006
Tyrosine-protein kinase Lyn	Homo sapiens (human)	0.732
Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens (human)	0.005
Dipeptidyl peptidase 4	Rattus norvegicus (Norway rat)	0.041
Tyrosine-protein kinase ZAP-70	Homo sapiens (human)	0.042
Tyrosine-protein kinase SYK	Homo sapiens (human)	0.167

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1

Other Studies

1 other study(ies) available for moxifloxacin and 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012

Article

Year

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012